Two Sigma Advisers’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-189,214
Closed -$40.2M 2711
2014
Q4
$40.2M Buy
189,214
+187,300
+9,786% +$37.2M 0.31% 69
2014
Q3
$341K Buy
+1,914
New +$318K ﹤0.01% 1784
2014
Q1
Sell
-61,314
Closed -$6.81M 2781
2013
Q4
$6.81M Buy
61,314
+39,500
+181% +$3.77M 0.07% 309
2013
Q3
$1.97M Sell
21,814
-1,643
-7% -$147K 0.02% 646
2013
Q2
$1.98M Buy
+23,457
New +$2.43M 0.03% 523

Other funds holding AGN

Two Sigma Advisers's AGN Position: Q1 2015 in Review

Two Sigma Advisers sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 189,214 shares — an estimated $40.2M sold.

Two Sigma Advisers first reported a position in AGN in Q2 2013 and held it in 5 quarters. The position peaked at $40.2M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Two Sigma Advisers reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Two Sigma Advisers sold 189,214 Allergan Inc shares in Q1 2015, an estimated $40.2M.
  • Two Sigma Advisers first reported a position in Allergan Inc in Q2 2013 and held it in 5 quarters.
  • Two Sigma Advisers's Allergan Inc position peaked at $40.2M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Two Sigma Advisers's 13F filing for Q1 2015, filed 15 May 2015.